Schachner, Luis F. http://orcid.org/0000-0001-6157-0937
Jooß, Kevin
Morgan, Marc A. http://orcid.org/0000-0002-0141-6273
Piunti, Andrea
Meiners, Matthew J.
Kafader, Jared O. http://orcid.org/0000-0002-5359-264X
Lee, Alexander S. http://orcid.org/0000-0001-6214-1990
Iwanaszko, Marta
Cheek, Marcus A.
Burg, Jonathan M.
Howard, Sarah A.
Keogh, Michael-Christopher http://orcid.org/0000-0002-2219-8623
Shilatifard, Ali http://orcid.org/0000-0002-7490-2854
Kelleher, Neil L. http://orcid.org/0000-0002-8815-3372
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (T32GM105538, P41GM108569, R44GM116584)
U.S. Department of Health & Human Services | NIH | NIH Office of the Director (S10OD025194)
U.S. Department of Health & Human Services | NIH | National Institute on Aging (RF1AG063903)
Howard Hughes Medical Institute (59008810)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (K99CA234434-01, R44CA212733, R44CA214076)
Article History
Received: 19 March 2020
Accepted: 21 December 2020
First Online: 15 February 2021
Competing interests
: N.L.K. serves as a consultant to Thermo Fisher Scientific. EpiCypher is a commercial developer and supplier of reagents, including the recombinant semi-synthetic modified nucleosomes (dNucs) used in this study. The other authors declare no competing interests.